Today I’m talking with Harry Rowland, co-founder and CEO of Endotronix. Endotronix was founded in 2007 and is developing an implantable pressure sensor that can be placed in the pulmonary artery outside the heart.
Dr. Rowland has led the company’s innovation, strategy and technology developments since the project began and has raised millions of dollars in funding. In this episode, he shares the exciting new prospects this technology offers as part of a complete health system that provides tools and feedbacks to help extend and improve patient’s lives.
- Dr. Rowland’s background in engineering and healthcare entrepreneurship
- Advanced heart failure, current standards of care and healthcare costs
- Endotronix implantable sensors and proactive heart disease management
- Raising capital for the business
- Perseverance and commitment as a startup
- Future of Endotronix and clinical testing
- Advice for new healthcare startups
- Engaging both patients and clinicians to make the product successful
Links and Resources Mentioned: